To evaluate the extent to which the nature and extent of any type of cancer, including mesothelioma cancer, oncologists will use the rubric system or "staging". This is just one of the yardsticks used to classify the malignancy. Additional criteria include identification of mesothelioma cell types and location of the tumor.
The system of "staging" will help doctors determine how far the mesothelioma cancer development of mesothelioma treatment asbestos and what is appropriate for the patient's malignancy.
Although the three staging systems in use today are different, but the trio is based on four main stage relative to the assessment of a tumor:
*Mesothelioma stage 1: Tumor confined to one organ or area and is relatively small.
*Mesothelioma stage 2: the size of the tumor has grown and has spread to one network or the other regions.
*Mesothelioma stage 3: Tumor has spread to surrounding areas or adjacent.
*Mesothelioma stage 4: the Tumor has spread to organs or distant areas of the body or "metastasis."
Mesothelioma in stage 4, the cancer has spread to the entire body of a patient and the patient's life expectancy of a mesothelioma sufferer won't be long anticipated.
Mesothelioma stage 4 prognosis
By Stage 4, mesothelioma prognosis, identified as end or terminal and in most cases, patients have less than a year to survive. In this condition, the doctor focuses on quality of life, offering palliative care that can at least alleviate the patient's sense of discomfort and pain is experienced.